Logo

Dharmacon Will Provide siRNA Library to Millennium

May 06, 2005

NEW YORK, May 6 (GenomeWeb News) - Dharmacon will supply Millennium Pharmaceuticals a genome-wide short interfering-RNA library corresponding to 22,000 human genes, the companies said yesterday.

 

A Dharmacon spokesperson declined to disclose financial details of the contract.

 

Millennium will use the siRNA library for drug discovery and target validation, said Leland Foster, president and CEO of the Biosciences group of Fisher Scientific International, Dharmacon's parent company.

 

Dharmacon developed the siRNA library using its SMARTselection and SMART pool technologies, the statement said.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.